Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2365-421X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals ; volume:6 ; number:1 ; day:12 ; month:2 ; year:2021 ; pages:1-22 ; date:12.2021
EJNMMI radiopharmacy and chemistry ; 6, Heft 1 (12.2.2021), 1-22, 12.2021
- Creator
-
Gillings, Nic
Hjelstuen, Olaug
Ballinger, Jim
Behe, Martin
Decristoforo, Clemens
Elsinga, Philip
Ferrari, Valentina
Peitl, Petra Kolenc
Koziorowski, Jacek
Laverman, Peter
Mindt, Thomas L.
Kiß, Oliver
Ocak, Meltem
Patt, Marianne
Todde, Sergio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41181-021-00123-2
- URN
-
urn:nbn:de:101:1-2021040313382360345370
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gillings, Nic
- Hjelstuen, Olaug
- Ballinger, Jim
- Behe, Martin
- Decristoforo, Clemens
- Elsinga, Philip
- Ferrari, Valentina
- Peitl, Petra Kolenc
- Koziorowski, Jacek
- Laverman, Peter
- Mindt, Thomas L.
- Kiß, Oliver
- Ocak, Meltem
- Patt, Marianne
- Todde, Sergio
- SpringerLink (Online service)
Other Objects (12)
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
EANM guideline on quality risk management for radiopharmaceuticals
EANM guideline on the validation of analytical methods for radiopharmaceuticals
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Are we “preparing” radiopharmaceuticals?
When is good, good enough? Methodological pragmatism for sustainable guideline development
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
EANM guideline on quality risk management for radiopharmaceuticals
EANM guideline on the validation of analytical methods for radiopharmaceuticals
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Are we “preparing” radiopharmaceuticals?
When is good, good enough? Methodological pragmatism for sustainable guideline development
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
EANM guideline on quality risk management for radiopharmaceuticals
EANM guideline on the validation of analytical methods for radiopharmaceuticals
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Development of no-carrier-added radioselenation methods for the preparation of radiopharmaceuticals
Are we “preparing” radiopharmaceuticals?
When is good, good enough? Methodological pragmatism for sustainable guideline development